Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment

Drug repositioning refers to new uses for existing drugs outside the scope of the original medical indications. This approach fastens the process of drug development allowing finding effective drugs with reduced side effects and lower costs. Colorectal cancer (CRC) is often diagnosed at advanced sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Anselmino, L. E., Baglioni, M. V., Malizia, F., Laluce, N. Cesatti, Etichetti, C. Borini, Marignac, V. L. Martínez, Rozados, V., Scharovsky, O. G., Girardini, J., Rico, M. J., Menacho Márquez, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047046/
https://www.ncbi.nlm.nih.gov/pubmed/33854147
http://dx.doi.org/10.1038/s41598-021-87525-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047046/
https://www.ncbi.nlm.nih.gov/pubmed/33854147
http://dx.doi.org/10.1038/s41598-021-87525-z

Ejemplares similares